NasVax
ShlomZion Shen
shlomzion.shen@nullgmail.com
+972-52-6517326
NasVax develops novel immunotherapeutic products.
The company has two major product candidates.
Oral anti-CD3 monoclonal antibody is an immunotherapeutic for treating inflammatory and autoimmune diseases, and BBS-based monoclonal antibody is an immunotherapeutic for Alzheimer's disease.
The company also has a portfolio of patents covering extensive innovative work in the fields of group –common pneumococcal vaccine ( a protein-based vaccine that could become part of a third-generation product) and vaxisome ® technology (an adjuvant-delivery system for enhancing the potency of vaccines and immunotherapeutics).
Get more BANG for your BUCK at industry events.
Aneeva's Event Optimization Service helps you drive sales and maximize ROI from industry events via pre-set sales meetings with targeted customers.